Fumihito Hosoi

1.6k citations

22 papers · 1.3k indexed · h-index 15

Co-authors: Mayumi Ono Michihiko Kuwano Yuji Basaki Yoshinao Oda Kosuke Watari Hiroto Izumi Kimitoshi Kohno Abbas Fotovati
Topics: Chronic Lymphocytic Leukemia Research (5 papers)HER2/EGFR in Cancer Research (4 papers)Mechanisms of cancer metastasis (4 papers)
Cited by: Oncology Molecular Biology Immunology
Journals: Journal of the American Chemical Society PLoS ONE Cancer Research
Partner nations: Japan United States Czechia

In The Last Decade

Fumihito Hosoi

21 papers receiving 1.3k citations

Peers

Countries citing papers authored by Fumihito Hosoi

Since Specialization

Citations

This map shows the geographic impact of Fumihito Hosoi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumihito Hosoi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumihito Hosoi more than expected).

Fields of papers citing papers by Fumihito Hosoi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumihito Hosoi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumihito Hosoi. The network helps show where Fumihito Hosoi may publish in the future.

Co-authorship network of co-authors of Fumihito Hosoi

This figure shows the co-authorship network connecting the top 25 collaborators of Fumihito Hosoi. A scholar is included among the top collaborators of Fumihito Hosoi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumihito Hosoi. Fumihito Hosoi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novel Bruton’s tyrosine kinase inhibitor TAS5315 suppresses the progression of inflammation and joint destruction in rodent collagen-induced arthritis 2023 ·PLoS ONE ·(unknown),(unknown),(unknown),(unknown),Daisuke Kajiwara,(unknown),(unknown),Kenji F. Tanaka,Atsushi Shimizu,Fumihito Hosoi	6
2	OP0075 TAS5315, A Novel Bruton's Tyrosine Kinase (BTK) Inhibitor, Demonstrates Potent Efficacy in Mouse Collagen-Induced Arthritis Model 2015 ·Annals of the Rheumatic Diseases ·Fumihito Hosoi,(unknown),(unknown),(unknown),(unknown),(unknown),Kazuya Yonekura,Yoshikazu Iwasawa,Eisaku Sasaki,Teruhiro Utsugi	4
3	The antitumor effect of a novel angiogenesis inhibitor (an octahydronaphthalene derivative) targeting both VEGF receptor and NF‐κB pathway 2011 ·International Journal of Cancer ·Kosuke Watari,(unknown),(unknown),(unknown),Tomohiro Shibata,Akihiko Kawahara,Fumihito Hosoi,Takashi Kuwano,Michihiko Kuwano,Mayumi Ono	25
4	Identification of sites subjected to serine/threonine phosphorylation by SGK1 affecting N-myc downstream-regulated gene 1 (NDRG1)/Cap43-dependent suppression of angiogenic CXC chemokine expression in human pancreatic cancer cells 2010 ·Biochemical and Biophysical Research Communications ·Yûichi Murakami,Fumihito Hosoi,Hiroto Izumi,Yuichiro Maruyama,(unknown),Kosuke Watari,Kimitoshi Kohno,Michihiko Kuwano,Mayumi Ono	70
5	Y-box binding protein-1 (YB-1) promotes cell cycle progression through CDC6-dependent pathway in human cancer cells 2010 ·European Journal of Cancer ·Yuji Basaki,Kenichi Taguchi,Hiroto Izumi,Yûichi Murakami,(unknown),Fumihito Hosoi,Kosuke Watari,Kenji Nakano,Hidetoshi Kawaguchi,Shinji Ohno,Kimitoshi Kohno,Mayumi Ono,Michihiko Kuwano	72
6	N-myc Downstream Regulated Gene 1/Cap43 Suppresses Tumor Growth and Angiogenesis of Pancreatic Cancer through Attenuation of Inhibitor of κB Kinase β Expression 2009 ·Cancer Research ·Fumihito Hosoi,Hiroto Izumi,Akihiko Kawahara,Yûichi Murakami,Hisafumi Kinoshita,Masayoshi Kage,Kazuto Nishio,Kimitoshi Kohno,Michihiko Kuwano,Mayumi Ono	88
7	N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin 2009 ·Human Pathology ·(unknown),Yoshinao Oda,(unknown),Kentaro Kuroiwa,Mayumi Ono,Fumihito Hosoi,Yuji Basaki,Shoji Tokunaga,Michihiko Kuwano,Seiji Naito,Masazumi Tsuneyoshi	50
8	Role of NDRG1/Cap43 in osteogenic differentiation 2009 ·Bone ·(unknown),Michihisa Zenmyo,Koji Hiraoka,(unknown),Nobuhiro Fukushima,Takahiro Hamada,Fumihito Hosoi,K Nagata,Setsuro Komiya,Masahiro Ono,M Kuwano	1
9	Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages 2008 ·Cancer Science ·Koji Hiraoka,Michihisa Zenmyo,Kosuke Watari,Haruo Iguchi,Abbas Fotovati,Yusuke Kimura,Fumihito Hosoi,(unknown),Kensei Nagata,Hiroyuki Osada,Mayumi Ono,Michihiko Kuwano	105
10	Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-κB activation 2008 ·Biochemical and Biophysical Research Communications ·Kosuke Watari,Shintaro Nakao,Abbas Fotovati,Yuji Basaki,Fumihito Hosoi,(unknown),Ryuichi Higuchi,Tomofumi Miyamoto,Michihiko Kuwano,Mayumi Ono	89
11	Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis 2007 ·Cancer Science ·Yusuke Kimura,Kosuke Watari,Abbas Fotovati,Fumihito Hosoi,Kosei Yasumoto,Hiroto Izumi,Kimitoshi Kohno,Kazuo Umezawa,Haruo Iguchi,Kazuo Shirouzu,(unknown),Michihiko Kuwano,Mayumi Ono	108
12	Expression profile of class I histone deacetylases in human cancer tissues 2007 ·Oncology Reports ·(unknown),Yoshinao Oda,Takashi Eguchi,Shin-ichi Aishima,Takashi Yao,Fumihito Hosoi,Yuji Basaki,Mayumi Ono,Michihiko Kuwano,Masao Tanaka,Masazumi Tsuneyoshi	281
13	Alteration of dihydropyrimidine dehydrogenase expression by IFN-α affects the antiproliferative effects of 5-fluorouracil in human hepatocellular carcinoma cells 2007 ·Molecular Cancer Therapeutics ·Shinji Oie,Mayumi Ono,(unknown),Fumihito Hosoi,Hirohisa Yano,Yuichiro Maruyama,Masamichi Kojiro,(unknown),Kazuyuki Hirano,Michihiko Kuwano,Yuji Yamada	14
14	A synthetic retinoid, TAC-101 (4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid), plus cisplatin: Potential new therapy for ovarian clear cell adenocarcinoma 2007 ·Gynecologic Oncology ·(unknown),Nao Suzuki,(unknown),(unknown),Fumihito Hosoi,Kenji Kitazato,Nobuyuki Susumu,Daisuke Aoki	1
15	High expression of insulin‐like growth factor binding protein‐3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma 2006 ·Cancer Science ·Shinichi Aishima,Yuji Basaki,Yoshinao Oda,(unknown),Yunosuke Nishihara,Kenichi Taguchi,Akinobu Taketomi,Yoshihiko Maehara,Fumihito Hosoi,Yuichiro Maruyama,Abbas Fotovati,Shinji Oie,Mayumi Ono,Takato Ueno,Michio Sata,Hirohisa Yano,Masamichi Kojiro,Michihiko Kuwano,Masazumi Tsuneyoshi	47
16	Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells 2006 ·Oncogene ·Y Basaki,Fumihito Hosoi,Yoshinao Oda,Abbas Fotovati,(unknown),Shinji Oie,Mayumi Ono,Hiroto Izumi,Kimitoshi Kohno,K. Sakai,Tatsu Shimoyama,Kazuto Nishio,M Kuwano	128
17	Antitumor Enediyne Chromoprotein C-1027: Mechanistic Investigation of the Chromophore-Mediated Self-Decomposition Pathway 2006 ·Journal of the American Chemical Society ·Masayuki Inoue,Toyonobu Usuki,Nayoung Lee,Masahiro Hirama,Toshiyuki Tanaka,Fumihito Hosoi,(unknown),TOSHIO OTANI	18
18	HER2 Overexpression Increases Sensitivity to Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, through Inhibition of HER2/HER3 Heterodimer Formation in Lung Cancer Cells 2005 ·Cancer Research ·Akira Hirata,Fumihito Hosoi,Miho Miyagawa,Shuichi Ueda,Seiji Naito,Teruhiko Fujii,Michihiko Kuwano,Mayumi Ono	97
19	A novel retinoid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), induces apoptosis of human ovarian carcinoma cells and shows potential as a new antitumor agent for clear cell adenocarcinoma 2004 ·Gynecologic Oncology ·Nao Suzuki,Daisuke Aoki,Shinji Oie,(unknown),Yūko Hasegawa,(unknown),Atsushi Suzuki,Nobuyuki Susumu,Fumihito Hosoi,Kenji Kitazato,Shiro Nozawa	11
20	Redox regulation by thioredoxin superfamily; protection against oxidative stress and aging 2000 ·Free Radical Research ·Toru Tanaka,Hajime Nakamura,Akira Nishiyama,Fumihito Hosoi,Hiroshi Masutani,Hiromi Wada,Junji Yodoi	129

About Fumihito Hosoi

Fumihito Hosoi is a scholar working on Genetics, Oncology and Toxicology, having authored 22 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (5 papers), HER2/EGFR in Cancer Research (4 papers) and Mechanisms of cancer metastasis (4 papers). The work is most often cited by research in Oncology (418 citations), Molecular Biology (933 citations) and Immunology (227 citations). Fumihito Hosoi has collaborated with scholars based in Japan, United States and Czechia. Frequent co-authors include Mayumi Ono, Michihiko Kuwano, Yuji Basaki, Yoshinao Oda, Kosuke Watari, Hiroto Izumi, Kimitoshi Kohno, Abbas Fotovati, Masazumi Tsuneyoshi and Takashi Eguchi. Their work appears in journals such as Journal of the American Chemical Society, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact